Navigation Links
Birth Defects Link With ACE Inhibitor Use, FDA Reports

Taking ACE inhibitor, a common BP medication during first trimester of pregnancy have greater risk of developing birth defects in babies - The Food and Drug Administration reports from data collected by researchers at// Vanderbilt University Medical Center.

The study, led by William Cooper, M.D., M.P.H., associate professor of Pediatrics at the Monroe Carell Jr. Children's Hospital at Vanderbilt, found infants born to mothers who took angiotensin converting enzyme inhibitors (ACE inhibitors) during the first trimester of pregnancy had an increased risk of major birth defects, compared with infants whose mothers did not take these medications.

Out of 29,507 infants whose TennCare records were examined for the study, 209 were exposed to ACE inhibitors in the first trimester only. When those babies were compared to the rest of the population, including babies exposed to other types of antihypertensive medications, they had more than double the risk of major birth defects, especially of the heart and central nervous system.

Cooper is first author on the study, which includes co-authors from the Departments of Pediatrics, Preventive Medicine and Biostatistics.

‘We knew ACE inhibitors were a possible cause of adverse fetal outcomes when exposure occurred later in pregnancy, but it has not been well studied in the first trimester,’ Cooper said. ‘We were very surprised that even after controlling for other risk factors, the TennCare records we examined showed a clear increase in a broad range of birth defects following first-trimester-only exposures.’

This research is important because of an increase in the number of women of childbearing age who develop high blood pressure and are prescribed ACE inhibitors. These drugs already carry a warning that they may cause injury and even death to the developing fetus when used during the second and third trimesters of pregnancy. The warning states that a woman should discontinue
'"/>




Page: 1 2

Related medicine news :

1. Birth weight key factor in heart diseases
2. FDA Approves Birth Control Skin Patch
3. IVF technique May Increase The Risk Of Birth Defects
4. Smoking Linked To Low Infant Birth Weight
5. Unpredictable Premature Birth
6. New Birth Control Pills increase the stroke risk
7. Epilepsy Drugs Can Enhance Risk of Birth Defects
8. Sex timing has no impact on risk of Birth defects
9. Birth weight may be influenced by genes
10. Dental Procedure Reduces Preterm Births
11. Low Birth Weight infants could have Problems in the Future

Post Your Comments:
(Date:11/23/2009)... Plastic and Reconstructive Surgery...In Brief i...ated on the most current journal news from the Ame...f the full studies highlighted here, or to arrange...ASPS Public Relations at (847) 228-9900 or media@p...us) November 23, 2009 -- Yes, Plastic Surgeons Hav...
(Date:11/23/2009)...Nov.23/PRNewswire/--UnitedConcordiaDental,oneofthe...yredesignedWebsite,www.unitedconcordia.comwhichpro...rs,employersanddentists. ,, "Thesiteboastsaclea...lgearedtowardhelpingvisitorsfindinformationquickly...commerceprojectdirector."Fresh,relevantcontent,cou...
(Date:11/23/2009)...Newswire/--James.G.Schwade,M.D.announcesthenewlyen...sattheCyberKnifeCenterofMiami,( www.cyberknifemia...apreciselytargetedintensedoseofradiationthatkillsc...ofthetreatmentcanlastfrom30minutestoonehour,andisu...berKnifeTreatmentCenterintheSoutheasternU.S.,theMi...
(Date:11/23/2009)...pport link between mental and physical health , ...g depressed might take as many years off your life...er, a combination of depression and anxiety appear... , Researchers came to their conclusions after ...60,000 people. During the four years after the sur...
(Date:11/23/2009)...mber 23, 2009 In the November issue of GIE: Gast... scientific journal of the American Society for Ga...anford University found that Barrett,s esophagus w...ndergoing endoscopic screening. Also in this issue...: Researchers from France, in the largest single-c...
Breaking Medicine News(10 mins):Health News:Plastic and Reconstructive Surgery...In Brief 2Health News:Plastic and Reconstructive Surgery...In Brief 3Health News:Depression May Up Death Risk to That of Smoking 2Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 2Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 3Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 4Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 5
...ports more than 60 orders for faster form of image...ion therapy, PALO ALTO, Calif., April 23 Varian ...as received more than 60 orders for,its new RapidA...ave also come in from Europe and Asia,since the pr...
..., April 23 The NCCA accredited the National,Exerc... Trainer,Certification for a five-year period, exp... Founded in 1992, NESTA is a professional certific...tion., NESTA received NCCA accreditation of its P...
...n urges Senators Cardin and Mikulski to quickly pa...BALTIMORE, April 23 AARP thanked the,supporters a...y Net Act of,2008, which passed today in the U.S. ..., "Today,s vote is a victory for all Marylanders ...
...s goal is to maintain strength, not gain it, while...ay News) -- If you,re an athlete or fitness enthus... or foot injury, you don,t necessarily have to sto...and not left in place for a long period of time," ...
...mber of Entries Available Through Charities and To...ounced today that,registration for the Bank of Ame... have signed on to complete the 26.2-mile race, ma.../www.newscom.com/cgi-bin/prnh/20050720/CLW086LOGO-...
...-thirds of people with these headaches suffer from...AY, April 23 (HealthDay News) -- People who have m... likely to suffer from serious skin pain and sensi...us allodynia is skin sensitivity and pain so sever...
Other Medicine News:Health News:Varian Medical Systems Announces Record Demand for New RapidArc(TM) Radiotherapy Treatment Capability 2Health News:Varian Medical Systems Announces Record Demand for New RapidArc(TM) Radiotherapy Treatment Capability 3Health News:Varian Medical Systems Announces Record Demand for New RapidArc(TM) Radiotherapy Treatment Capability 4Health News:Varian Medical Systems Announces Record Demand for New RapidArc(TM) Radiotherapy Treatment Capability 5Health News:The National Exercise & Sports Trainers Association Receives Accreditation of Its Personal Fitness Trainer Certification From the National Commission for Certifying Agencies (NCCA) 2Health News:AARP Thanks Maryland's Representatives for Supporting Bill to Protect People in Medicaid 2Health News:Exercise Plays Role in Recovery From Sports Injuries 2Health News:2008 Bank of America Chicago Marathon Registration Closes as Race Reaches 45,000 Participant Capacity 2Health News:Skin Pain, Sensitivity Rises With Migraine 2Health News:Skin Pain, Sensitivity Rises With Migraine 3
(Date:11/23/2009)...,Nov.23/PRNewswire/--LightSciencesOncology,Inc.(LS...oftheBoard,Elekta,toanewlycreatedseatonitsboardofd...medical-productcompanies,includingElekta,tomarketl...gsadditionalstrengthinbusinessdevelopmenttotheboar...ighisaworldleaderincancer-therapybusinessdevelopme...
(Date:11/23/2009)....,Nov.23/PRNewswire-FirstCall/-- CumberlandPharmac...p-lineresultsfromastudyevaluatingthesafetyandeffic...inhospitalizedburnpatients. ,, Statisticalsigni...everinburnpatientsoverthefirst24hoursoftreatment.T...rddegreeburnscoveringmorethan10percenttotalbodysur...
(Date:11/23/2009)...s,Nov.23/PRNewswire-FirstCall/--WoundManagementTec...ingproviderofspecialtymedicalproducts,announcedtha...comprehensivemanagementbusinessupdatetoillustratet...2009salesincreased33.5%to$102,926vs.Q32008salesof$...asedto$3,327,892vs.Q32008shareholderequityof$(321,...
Breaking Medicine Technology:Light Sciences Oncology Elects Akbar Seddigh, Chairman of Elekta AB to Its Board of Directors 2Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients 2Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 4Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 5Futronic Windows 7 Biometric Framework Driver is Signed by Microsoft 10364 1Futronic Windows 7 Biometric Framework Driver is Signed by Microsoft 10364 2WarrantyElephant Launches 26quot 3BMediElephant 26quot 3B a New Medication Reminder Service Inspired by WarrantyElephant User Rhonda Lewis Founder o 59503 1WarrantyElephant Launches 26quot 3BMediElephant 26quot 3B a New Medication Reminder Service Inspired by WarrantyElephant User Rhonda Lewis Founder o 59503 2You Me and Tea is Pleased to Announce the Website Debut of youmeandtea com 59498 1You Me and Tea is Pleased to Announce the Website Debut of youmeandtea com 59498 2
..., Calif., June 2 ,Bayer HealthCare Pharmaceuticals...XX ) today announced the presentation of new clini...elopment program for Nexavar(R),(sorafenib) tablet...gastric and ovarian cancers. Nexavar is currently ...nt of patients with unresectable liver cancer and,...
...edarex, Inc.,(Nasdaq: MEDX ) today announced prel...1106 (ONO-4538: development code of Ono Pharmaceut...Data presented from patients with,recurrent or tre... safety,tolerability and pharmacokinetic profile o...vidence of anti-tumor activity was observed,includ...
Other Medicine Technology:New Nexavar Data Presented in Multiple Tumor Types at 44th American Society of Clinical Oncology Annual Meeting 2New Nexavar Data Presented in Multiple Tumor Types at 44th American Society of Clinical Oncology Annual Meeting 3New Nexavar Data Presented in Multiple Tumor Types at 44th American Society of Clinical Oncology Annual Meeting 4New Nexavar Data Presented in Multiple Tumor Types at 44th American Society of Clinical Oncology Annual Meeting 5New Nexavar Data Presented in Multiple Tumor Types at 44th American Society of Clinical Oncology Annual Meeting 6Preliminary Data from Ongoing Phase 1 Data of Investigational Anti-PD-1 Antibody Presented at American Society of Clinical Oncology Annual Meeting 2Preliminary Data from Ongoing Phase 1 Data of Investigational Anti-PD-1 Antibody Presented at American Society of Clinical Oncology Annual Meeting 3Preliminary Data from Ongoing Phase 1 Data of Investigational Anti-PD-1 Antibody Presented at American Society of Clinical Oncology Annual Meeting 4
Renu Multiplus Lubricating and Rewetting Drops
Sensitive Eyes Saline/Cleaning Solution
Sensitive Eyes Plus Saline Solution
Renu 1-Step Enzymatic Cleaner
Medicine Products: